🚀 VC round data is live in beta, check it out!
Med Life Valuation Multiples
Discover revenue and EBITDA valuation multiples for Med Life and similar public comparables like Ramsay Santé, Aevis Victoria, Terveystalo, Astrana Health and more.
Med Life Overview
About Med Life
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
Founded
1996
HQ
Employees
7.6K
Website
Sectors
Financials (LTM)
EV
$2B
Med Life Financials
Med Life reported last 12-month revenue of $758M and EBITDA of $116M.
In the same LTM period, Med Life generated $116M in EBITDA and $15M in net income.
Revenue (LTM)
Med Life P&L
In the most recent fiscal year, Med Life reported revenue of $615M and EBITDA of $88M.
Med Life expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $758M | XXX | $615M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $502M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 82% | XXX | XXX | XXX |
| EBITDA | $116M | XXX | $88M | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 7% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | $15M | XXX | $6M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | — | — | $282M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Med Life Stock Performance
Med Life has current market cap of $1B, and enterprise value of $2B.
Market Cap Evolution
Med Life's stock price is $2.63.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $1B | 0.3% | XXX | XXX | XXX | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMed Life Valuation Multiples
Med Life trades at 2.4x EV/Revenue multiple, and 15.4x EV/EBITDA.
EV / Revenue (LTM)
Med Life Financial Valuation Multiples
As of April 9, 2026, Med Life has market cap of $1B and EV of $2B.
Equity research analysts estimate Med Life's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Med Life has a P/E ratio of 90.4x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | 2.4x | XXX | 2.9x | XXX | XXX | XXX |
| EV/EBITDA | 15.4x | XXX | 20.4x | XXX | XXX | XXX |
| EV/EBIT | 35.5x | XXX | 52.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 3.6x | XXX | XXX | XXX |
| P/E | 90.4x | XXX | 241.0x | XXX | XXX | XXX |
| EV/FCF | 180.2x | XXX | 281.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Med Life Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Med Life Margins & Growth Rates
Med Life's revenue in the last 12 month grew by 12%.
Med Life's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Med Life's rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Med Life's rule of X is 48% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Med Life Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 39% | XXX | 19% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 30% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 48% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 76% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Med Life Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Ramsay Santé | XXX | XXX | XXX | XXX | XXX | XXX |
| Aevis Victoria | XXX | XXX | XXX | XXX | XXX | XXX |
| Terveystalo | XXX | XXX | XXX | XXX | XXX | XXX |
| Astrana Health | XXX | XXX | XXX | XXX | XXX | XXX |
| U.S. Physical Therapy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Med Life M&A Activity
Med Life acquired XXX companies to date.
Last acquisition by Med Life was on XXXXXXXX, XXXXX. Med Life acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Med Life
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMed Life Investment Activity
Med Life invested in XXX companies to date.
Med Life made its latest investment on XXXXXXXX, XXXXX. Med Life invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Med Life
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Med Life
| When was Med Life founded? | Med Life was founded in 1996. |
| Where is Med Life headquartered? | Med Life is headquartered in Romania. |
| How many employees does Med Life have? | As of today, Med Life has over 7K employees. |
| Who is the CEO of Med Life? | Med Life's CEO is Mihail Marcu. |
| Is Med Life publicly listed? | Yes, Med Life is a public company listed on Bucharest Stock Exchange. |
| What is the stock symbol of Med Life? | Med Life trades under M ticker. |
| When did Med Life go public? | Med Life went public in 2016. |
| Who are competitors of Med Life? | Med Life main competitors are Ramsay Santé, Aevis Victoria, Terveystalo, Astrana Health. |
| What is the current market cap of Med Life? | Med Life's current market cap is $1B. |
| What is the current revenue of Med Life? | Med Life's last 12 months revenue is $758M. |
| What is the current revenue growth of Med Life? | Med Life revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Med Life? | Current revenue multiple of Med Life is 2.4x. |
| Is Med Life profitable? | Yes, Med Life is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Med Life? | Med Life's last 12 months EBITDA is $116M. |
| What is Med Life's EBITDA margin? | Med Life's last 12 months EBITDA margin is 15%. |
| What is the current EV/EBITDA multiple of Med Life? | Current EBITDA multiple of Med Life is 15.4x. |
| What is the current FCF of Med Life? | Med Life's last 12 months FCF is $10M. |
| What is Med Life's FCF margin? | Med Life's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Med Life? | Current FCF multiple of Med Life is 180.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.